Professors David Segal and Deborah Lieu have received Discovery Stage Research Projects awards from the California Institute for Regenerative Medicine (CIRM). The grants will fund cell gene therapy for Angelman syndrome and building the first biopacemaker
In a new study, an artificial intelligence algorithm exceeded the performance of a widely available commercial system in nearly all examined diagnoses.
Stem cell models derived from people with specific genomic variation recapitulate aspects of their autism spectrum disorder, providing a valuable model to study the condition and look for therapeutic interventions.
The California Institute for Regenerative Medicine has approved a trio of awards, totaling approximately $4 million, to UC San Diego School of Medicine researchers to advance studies of new stem cell-based treatments for multiple types of cancer and amyotrophic lateral sclerosis.